Collectively, findings uncovered in the current study unravel a regulatory network implicated in the pathogenesis and progression of CRC, wherein SP1 up-regulates TUG1, which activates the ERK pathway via miR-421-induced down-regulation of KDM2A. This evidence concerns the gene SP1 and colorectal carcinoma.